The pharmaceutical field is experiencing a major shift in glucose care with the emergence of GLP-1 transdermal devices. These groundbreaking methods offer a potentially simple choice to needle injections for individuals managing type 2 diabetes. By circumventing the need for frequent injections, GLP-1 skin devices promise to enhance user complia… Read More